FDA approved Dawnzera in US as first and only RNA-targeted prophylactic treatment for hereditary angioedema
Dawnzera demonstrated significant and sustained HAE attack rate reduction and long-term disease control
Dawnzera demonstrated significant and sustained HAE attack rate reduction and long-term disease control
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
Rocket will also collaborate with investigators to implement an immunomodulatory regimen more closely reflecting that administered in the Phase 1 pediatric cohort
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
NATCO holds the first-to-file status for this product and will have 180-day generic drug exclusivity
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
The patient had been battling DFSP for over eight years, enduring multiple recurrences despite three previous surgeries
According to IQVIA sales data for the 12-month period ending June 2025, the Mycamine for Injection, 50 mg/vial and 100 mg/vial market achieved annual sales of approximately $60.7 million
Macitentan tablets are an endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension
Subscribe To Our Newsletter & Stay Updated